Using the ATTC/NIDA Blending Products to Affect Change – Part 3 – MIA-Step
Using the ATTC/NIDA Blending Products to Affect Change – Part 3 – MIA-Step – Christine Higgins, MA, Dissemination Specialist for the Mid-Atlantic Node of Clinical Trials Network provides an Introduction to MIA-Step (Motivational Interviewing Assessment: Supervisory Tools for Enhancing Proficiency). This conference took place on July 13, 2012 in the Baltimore-Washington Metro area. It was sponsored by the Central East Addiction Technology Transfer Center (a program of the Danya Institute), and the Mid-Atlantic Node Clinical Trials Network. It featured presentations on the Blending Products which are a collaborative effort of the The National Drug Abuse Treatment Clinical Trials Network and the National Institute of Drug Abuse/Substance Abuse and Mental Health Services Administrations Blending Initiative to disseminate trestmernt and training products based on results conducted by the NIDA Clinical Trials Network. The audience was made up of practitioners in the Substance Abuse Treatment workforce -us tools in the Blending products suite and give them an opportunity to learn how to implement a particular evidence based practice. More information about the NIDA Blending Initiative and its products is available here: www.drugabuse.gov
Area tries to prepare for vague law
Filed under: drug treatment programs in massachusetts
The vaguely worded ballot question, which passed by a near 2-1 margin, makes it legal for citizens with a doctor's note to purchase and consume marijuana for medical treatment. Only two communities in the state, Lawrence and Mendon, voted against the …
Read more on The Salem News
Mass. rule would allow drug sharing in crisis
Filed under: drug treatment programs in massachusetts
BOSTON (AP) — Hospitals in Massachusetts would be allowed to share compounded medications in the event of future drug shortages under an emergency rule approved Wednesday by state health regulators. The new regulation adopted by … In an unrelated …
Read more on Seattle Post Intelligencer